DDX3X and ovarian carcinoma: The current study found that although total DDX3X expression was not distinct between cisplatin-sensitive and cisplatin-resistant ovarian cancer cells, while its recruitment on PHGDH mRNA was augmented in cisplatin-resistant ovarian cancer cells.